Invacare Corporation Logo

Invacare Corporation

IVC

(0.8)
Stock Price

0,66 USD

-23.51% ROA

-46.11% ROE

-0.26x PER

Market Cap.

24.910.286,00 USD

599.96% DER

0% Yield

-13.63% NPM

Invacare Corporation Stock Analysis

Invacare Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Invacare Corporation Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.55x), the stock offers substantial upside potential at a bargain price.

2 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

3 ROE

Negative ROE (-132.76%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-28.88%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The company has a high debt to equity ratio (600%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-6), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Invacare Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Invacare Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Invacare Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Invacare Corporation Revenue
Year Revenue Growth
1985 94.300.000
1986 111.500.000 15.43%
1987 130.800.000 14.76%
1988 160.800.000 18.66%
1989 186.100.000 13.59%
1990 229.800.000 19.02%
1991 263.200.000 12.69%
1992 305.200.000 13.76%
1993 365.500.000 16.5%
1994 411.100.000 11.09%
1995 504.000.000 18.43%
1996 619.500.000 18.64%
1997 653.400.000 5.19%
1998 797.500.000 18.07%
1999 878.300.000 9.2%
2000 1.013.162.000 13.31%
2001 1.053.639.000 3.84%
2002 1.089.161.000 3.26%
2003 1.247.176.000 12.67%
2004 1.403.327.000 11.13%
2005 1.529.732.000 8.26%
2006 1.498.035.000 -2.12%
2007 1.602.237.000 6.5%
2008 1.755.694.000 8.74%
2009 1.693.136.000 -3.69%
2010 1.722.081.000 1.68%
2011 1.801.130.000 4.39%
2012 1.455.461.000 -23.75%
2013 1.352.359.000 -7.62%
2014 1.270.163.000 -6.47%
2015 1.142.338.000 -11.19%
2016 1.047.474.000 -9.06%
2017 966.497.000 -8.38%
2018 972.347.000 0.6%
2019 927.964.000 -4.78%
2020 850.689.000 -9.08%
2021 872.457.000 2.5%
2022 741.733.000 -17.62%
2023 661.924.000 -12.06%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Invacare Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Invacare Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 112.200.000 100%
1996 136.100.000 17.56%
1997 160.100.000 14.99%
1998 157.600.000 -1.59%
1999 177.600.000 11.26%
2000 201.543.000 11.88%
2001 195.574.000 -3.05%
2002 220.296.000 11.22%
2003 262.015.000 15.92%
2004 297.124.000 11.82%
2005 341.782.000 13.07%
2006 373.846.000 8.58%
2007 366.846.000 -1.91%
2008 398.254.000 7.89%
2009 0 0%
2010 411.513.000 100%
2011 422.099.000 2.51%
2012 414.502.000 -1.83%
2013 401.823.000 -3.16%
2014 383.913.000 -4.67%
2015 319.847.000 -20.03%
2016 303.781.000 -5.29%
2017 296.816.000 -2.35%
2018 281.906.000 -5.29%
2019 260.061.000 -8.4%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Invacare Corporation EBITDA
Year EBITDA Growth
1985 400.000
1986 7.500.000 94.67%
1987 7.500.000 0%
1988 11.600.000 35.34%
1989 10.000.000 -16%
1990 20.500.000 51.22%
1991 31.000.000 33.87%
1992 37.500.000 17.33%
1993 45.800.000 18.12%
1994 54.600.000 16.12%
1995 66.100.000 17.4%
1996 81.700.000 19.09%
1997 23.600.000 -246.19%
1998 98.900.000 76.14%
1999 94.000.000 -5.21%
2000 129.685.000 27.52%
2001 99.838.000 -29.9%
2002 123.168.000 18.94%
2003 133.644.000 7.84%
2004 142.688.000 6.34%
2005 111.826.000 -27.6%
2006 -271.813.000 141.14%
2007 58.207.000 566.98%
2008 95.245.000 38.89%
2009 120.991.000 21.28%
2010 95.492.000 -26.7%
2011 52.433.000 -82.12%
2012 67.784.000 22.65%
2013 86.008.000 21.19%
2014 -14.692.000 685.41%
2015 10.861.000 235.27%
2016 953.000 -1039.66%
2017 -28.712.000 103.32%
2018 9.790.000 393.28%
2019 9.541.000 -2.61%
2020 25.328.000 62.33%
2021 2.009.000 -1160.73%
2022 -80.466.000 102.5%
2023 -39.860.000 -101.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Invacare Corporation Gross Profit
Year Gross Profit Growth
1985 28.000.000
1986 36.600.000 23.5%
1987 42.400.000 13.68%
1988 52.100.000 18.62%
1989 56.900.000 8.44%
1990 76.700.000 25.81%
1991 92.700.000 17.26%
1992 107.400.000 13.69%
1993 126.700.000 15.23%
1994 145.800.000 13.1%
1995 180.400.000 19.18%
1996 219.400.000 17.78%
1997 216.700.000 -1.25%
1998 262.300.000 17.38%
1999 297.200.000 11.74%
2000 339.844.000 12.55%
2001 318.347.000 -6.75%
2002 327.398.000 2.76%
2003 374.661.000 12.61%
2004 418.592.000 10.49%
2005 448.505.000 6.67%
2006 417.070.000 -7.54%
2007 446.304.000 6.55%
2008 488.892.000 8.71%
2009 493.194.000 0.87%
2010 509.641.000 3.23%
2011 518.478.000 1.7%
2012 444.901.000 -16.54%
2013 377.466.000 -17.87%
2014 347.388.000 -8.66%
2015 312.824.000 -11.05%
2016 283.627.000 -10.29%
2017 269.251.000 -5.34%
2018 267.676.000 -0.59%
2019 262.067.000 -2.14%
2020 245.252.000 -6.86%
2021 239.106.000 -2.57%
2022 175.393.000 -36.33%
2023 175.376.000 -0.01%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Invacare Corporation Net Profit
Year Net Profit Growth
1985 -1.100.000
1986 3.400.000 132.35%
1987 2.400.000 -41.67%
1988 5.100.000 52.94%
1989 2.600.000 -96.15%
1990 7.600.000 65.79%
1991 14.100.000 46.1%
1992 17.700.000 20.34%
1993 22.100.000 19.91%
1994 26.400.000 16.29%
1995 32.200.000 18.01%
1996 38.900.000 17.22%
1997 1.600.000 -2331.25%
1998 45.800.000 96.51%
1999 41.500.000 -10.36%
2000 59.911.000 30.73%
2001 35.190.000 -70.25%
2002 64.770.000 45.67%
2003 71.409.000 9.3%
2004 75.197.000 5.04%
2005 48.852.000 -53.93%
2006 -317.774.000 115.37%
2007 1.190.000 26803.7%
2008 38.551.000 96.91%
2009 41.179.000 6.38%
2010 25.341.000 -62.5%
2011 -4.113.000 716.12%
2012 1.827.000 325.12%
2013 33.051.000 94.47%
2014 -56.070.000 158.95%
2015 -26.190.000 -114.09%
2016 -42.856.000 38.89%
2017 -76.541.000 44.01%
2018 -43.922.000 -74.27%
2019 -53.327.000 17.64%
2020 -28.280.000 -88.57%
2021 -45.563.000 37.93%
2022 -101.071.000 54.92%
2023 -164.708.000 38.64%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Invacare Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 1 0%
1992 1 0%
1993 1 0%
1994 1 0%
1995 1 100%
1996 1 0%
1997 0 0%
1998 2 100%
1999 1 0%
2000 2 0%
2001 1 0%
2002 2 50%
2003 2 0%
2004 2 0%
2005 2 -100%
2006 -10 110%
2007 0 0%
2008 1 100%
2009 1 0%
2010 1 0%
2011 0 0%
2012 0 0%
2013 1 100%
2014 -2 200%
2015 -1 0%
2016 -1 100%
2017 -2 50%
2018 -1 -100%
2019 -2 0%
2020 -1 0%
2021 -1 100%
2022 -3 50%
2023 -4 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Invacare Corporation Free Cashflow
Year Free Cashflow Growth
1989 -26.000.000
1990 -6.900.000 -276.81%
1991 -1.800.000 -283.33%
1992 17.300.000 110.4%
1993 18.600.000 6.99%
1994 20.600.000 9.71%
1995 32.500.000 36.62%
1996 11.700.000 -177.78%
1997 -10.000.000 217%
1998 -108.600.000 90.79%
1999 -91.300.000 -18.95%
2000 51.981.000 275.64%
2001 38.296.000 -35.73%
2002 102.072.000 62.48%
2003 78.866.000 -29.42%
2004 56.921.000 -38.55%
2005 45.430.000 -25.29%
2006 39.948.000 -13.72%
2007 59.032.000 32.33%
2008 56.457.000 -4.56%
2009 137.664.000 58.99%
2010 104.854.000 -31.29%
2011 76.918.000 -36.32%
2012 42.200.000 -82.27%
2013 -4.104.000 1128.27%
2014 -3.435.000 -19.48%
2015 -12.900.000 73.37%
2016 -66.764.000 80.68%
2017 -40.343.000 -65.49%
2018 -56.246.000 28.27%
2019 -8.131.000 -591.75%
2020 -387.000 -2001.03%
2021 -32.007.000 98.79%
2022 -59.029.000 45.78%
2023 -32.592.000 -81.11%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Invacare Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 100.000
1990 19.200.000 99.48%
1991 10.200.000 -88.24%
1992 31.800.000 67.92%
1993 30.600.000 -3.92%
1994 31.500.000 2.86%
1995 43.700.000 27.92%
1996 34.300.000 -27.41%
1997 37.900.000 9.5%
1998 50.000.000 24.2%
1999 72.800.000 31.32%
2000 78.426.000 7.17%
2001 58.478.000 -34.11%
2002 124.181.000 52.91%
2003 109.526.000 -13.38%
2004 98.324.000 -11.39%
2005 76.947.000 -27.78%
2006 61.737.000 -24.64%
2007 79.100.000 21.95%
2008 76.414.000 -3.52%
2009 155.663.000 50.91%
2010 122.207.000 -27.38%
2011 99.078.000 -23.34%
2012 62.291.000 -59.06%
2013 10.054.000 -519.56%
2014 8.892.000 -13.07%
2015 -5.378.000 265.34%
2016 -56.613.000 90.5%
2017 -25.774.000 -119.65%
2018 -46.423.000 44.48%
2019 2.743.000 1792.42%
2020 21.917.000 87.48%
2021 -14.309.000 253.17%
2022 -55.251.000 74.1%
2023 -30.614.000 -80.48%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Invacare Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 26.100.000
1990 26.100.000 0%
1991 12.000.000 -117.5%
1992 14.500.000 17.24%
1993 12.000.000 -20.83%
1994 10.900.000 -10.09%
1995 11.200.000 2.68%
1996 22.600.000 50.44%
1997 47.900.000 52.82%
1998 158.600.000 69.8%
1999 164.100.000 3.35%
2000 26.445.000 -520.53%
2001 20.182.000 -31.03%
2002 22.109.000 8.72%
2003 30.660.000 27.89%
2004 41.403.000 25.95%
2005 31.517.000 -31.37%
2006 21.789.000 -44.65%
2007 20.068.000 -8.58%
2008 19.957.000 -0.56%
2009 17.999.000 -10.88%
2010 17.353.000 -3.72%
2011 22.160.000 21.69%
2012 20.091.000 -10.3%
2013 14.158.000 -41.91%
2014 12.327.000 -14.85%
2015 7.522.000 -63.88%
2016 10.151.000 25.9%
2017 14.569.000 30.32%
2018 9.823.000 -48.32%
2019 10.874.000 9.67%
2020 22.304.000 51.25%
2021 17.698.000 -26.03%
2022 3.778.000 -368.45%
2023 1.978.000 -91%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Invacare Corporation Equity
Year Equity Growth
1985 17.500.000
1986 20.900.000 16.27%
1987 24.500.000 14.69%
1988 30.100.000 18.6%
1989 32.100.000 6.23%
1990 41.900.000 23.39%
1991 86.700.000 51.67%
1992 114.000.000 23.95%
1993 135.000.000 15.56%
1994 164.000.000 17.68%
1995 201.300.000 18.53%
1996 238.600.000 15.63%
1997 236.400.000 -0.93%
1998 280.900.000 15.84%
1999 318.900.000 11.92%
2000 349.773.000 8.83%
2001 381.550.000 8.33%
2002 480.312.000 20.56%
2003 613.188.000 21.67%
2004 753.438.000 18.61%
2005 752.688.000 -0.1%
2006 485.364.000 -55.08%
2007 554.043.000 12.4%
2008 480.528.000 -15.3%
2009 701.237.000 31.47%
2010 652.411.000 -7.48%
2011 626.525.000 -4.13%
2012 620.989.000 -0.89%
2013 670.809.000 7.43%
2014 565.322.000 -18.66%
2015 462.818.000 -22.15%
2016 422.387.000 -9.57%
2017 423.294.000 0.21%
2018 359.147.000 -17.86%
2019 308.516.000 -16.41%
2020 333.846.000 7.59%
2021 357.255.000 6.55%
2022 81.092.000 -340.56%
2023 45.939.000 -76.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Invacare Corporation Assets
Year Assets Growth
1985 55.500.000
1986 64.000.000 13.28%
1987 80.000.000 20%
1988 102.300.000 21.8%
1989 122.900.000 16.76%
1990 138.300.000 11.14%
1991 162.300.000 14.79%
1992 262.400.000 38.15%
1993 286.400.000 8.38%
1994 337.500.000 15.14%
1995 408.800.000 17.44%
1996 509.600.000 19.78%
1997 529.900.000 3.83%
1998 738.800.000 28.28%
1999 955.300.000 22.66%
2000 951.855.000 -0.36%
2001 914.537.000 -4.08%
2002 906.703.000 -0.86%
2003 1.108.213.000 18.18%
2004 1.628.124.000 31.93%
2005 1.622.953.000 -0.32%
2006 1.490.451.000 -8.89%
2007 1.500.042.000 0.64%
2008 1.314.473.000 -14.12%
2009 1.359.501.000 3.31%
2010 1.280.400.000 -6.18%
2011 1.281.054.000 0.05%
2012 1.262.294.000 -1.49%
2013 1.096.434.000 -15.13%
2014 963.731.000 -13.77%
2015 838.143.000 -14.98%
2016 903.743.000 7.26%
2017 1.066.033.000 15.22%
2018 885.855.000 -20.34%
2019 852.126.000 -3.96%
2020 945.981.000 9.92%
2021 909.531.000 -4.01%
2022 770.969.000 -17.97%
2023 762.116.000 -1.16%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Invacare Corporation Liabilities
Year Liabilities Growth
1985 38.000.000
1986 43.100.000 11.83%
1987 55.500.000 22.34%
1988 72.200.000 23.13%
1989 90.800.000 20.48%
1990 96.400.000 5.81%
1991 75.600.000 -27.51%
1992 148.400.000 49.06%
1993 151.400.000 1.98%
1994 173.500.000 12.74%
1995 207.500.000 16.39%
1996 271.000.000 23.43%
1997 293.500.000 7.67%
1998 457.900.000 35.9%
1999 636.400.000 28.05%
2000 602.082.000 -5.7%
2001 532.987.000 -12.96%
2002 426.391.000 -25%
2003 495.025.000 13.86%
2004 874.686.000 43.41%
2005 790.641.000 -10.63%
2006 1.005.087.000 21.34%
2007 945.999.000 -6.25%
2008 833.945.000 -13.44%
2009 658.264.000 -26.69%
2010 627.989.000 -4.82%
2011 654.529.000 4.05%
2012 641.305.000 -2.06%
2013 425.625.000 -50.67%
2014 398.409.000 -6.83%
2015 375.325.000 -6.15%
2016 481.356.000 22.03%
2017 642.739.000 25.11%
2018 526.708.000 -22.03%
2019 543.610.000 3.11%
2020 612.135.000 11.19%
2021 552.276.000 -10.84%
2022 689.877.000 19.95%
2023 716.177.000 3.67%

Invacare Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
13.6
Net Income per Share
-2.53
Price to Earning Ratio
-0.26x
Price To Sales Ratio
0.05x
POCF Ratio
-0.43
PFCF Ratio
-0.4
Price to Book Ratio
0.55
EV to Sales
0.45
EV Over EBITDA
-4.01
EV to Operating CashFlow
-3.98
EV to FreeCashFlow
-3.78
Earnings Yield
-3.83
FreeCashFlow Yield
-2.49
Market Cap
0,02 Bil.
Enterprise Value
0,23 Bil.
Graham Number
8.29
Graham NetNet
-14.09

Income Statement Metrics

Net Income per Share
-2.53
Income Quality
0.61
ROE
-1.39
Return On Assets
-0.13
Return On Capital Employed
-0.13
Net Income per EBT
1.03
EBT Per Ebit
1.41
Ebit per Revenue
-0.09
Effective Tax Rate
-0.03

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0
Gross Profit Margin
0.24
Operating Profit Margin
-0.09
Pretax Profit Margin
-0.13
Net Profit Margin
-0.14

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.55
Free CashFlow per Share
-1.63
Capex to Operating CashFlow
0.05
Capex to Revenue
-0.01
Capex to Depreciation
-0.2
Return on Invested Capital
-0.17
Return on Tangible Assets
-0.24
Days Sales Outstanding
58.33
Days Payables Outstanding
67.3
Days of Inventory on Hand
96.08
Receivables Turnover
6.26
Payables Turnover
5.42
Inventory Turnover
3.8
Capex per Share
-0.08

Balance Sheet

Cash per Share
1,74
Book Value per Share
1,21
Tangible Book Value per Share
-8.08
Shareholders Equity per Share
1.21
Interest Debt per Share
7.91
Debt to Equity
6
Debt to Assets
0.36
Net Debt to EBITDA
-3.58
Current Ratio
1.46
Tangible Asset Value
-0,31 Bil.
Net Current Asset Value
-0,43 Bil.
Invested Capital
6
Working Capital
0,09 Bil.
Intangibles to Total Assets
0.46
Average Receivables
0,09 Bil.
Average Payables
0,09 Bil.
Average Inventory
108098000
Debt to Market Cap
11.06

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Invacare Corporation Dividends
Year Dividends Growth
1984 0
1991 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%

Invacare Corporation Profile

About Invacare Corporation

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

CEO
Mr. Matthew E. Monaghan
Employee
3.000
Address
One Invacare Way
Elyria, 44035-4190

Invacare Corporation Executives & BODs

Invacare Corporation Executives & BODs
# Name Age
1 Mr. Joost Beltman
Senior Vice President of Europe Central & Global Categories
70
2 Lois Lee CTP
Director of Treasury & Investor Relations
70
3 Ms. Angela Goodwin
Senior Vice President & Chief Information Technology Officer
70
4 Ms. Cintia Ferreira
Chief HR Officer
70
5 Ms. Kathleen P. Leneghan
Senior Vice President & Chief Financial Officer
70
6 Mr. Anthony C. LaPlaca
Senior Vice President, Gen. Counsel, Chief Admin. Officer & Sec.
70

Invacare Corporation Competitors